BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 31262751)

  • 41. The Copenhagen criteria for Sjögren's syndrome.
    Manthorpe R; Oxholm P; Prause JU; Schiødt M
    Scand J Rheumatol Suppl; 1986; 61():19-21. PubMed ID: 3473631
    [No Abstract]   [Full Text] [Related]  

  • 42. Autoantibodies to alpha-fodrin in primary Sjögren's syndrome and SLE detected by an in vitro transcription and translation assay.
    Nordmark G; Rorsman F; Rönnblom L; Cajander S; Taussig MJ; Kämpe O; Winqvist O
    Clin Exp Rheumatol; 2003; 21(1):49-56. PubMed ID: 12673889
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Systemic lupus erythematosus and Sjögren's syndrome.
    Diamond B
    Curr Opin Rheumatol; 2007 Sep; 19(5):405. PubMed ID: 17762602
    [No Abstract]   [Full Text] [Related]  

  • 44. Anti-52 kDa Ro(SSA) autoantibodies in different autoimmune diseases preferentially recognize epitopes on the central region of the antigen.
    Dorner T; Feist E; Wagenmann A; Kato T; Yamamoto K; Nishioka K; Burmester GR; Hiepe F
    J Rheumatol; 1996 Mar; 23(3):462-8. PubMed ID: 8832984
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Neuroendocrine changes in systemic lupus erythematosus and Sjögren's syndrome.
    Fox RA; Moore PM; Isenberg DA
    Baillieres Clin Rheumatol; 1996 May; 10(2):333-47. PubMed ID: 8911652
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Criteria for Sjögren's syndrome in Japan.
    Homma M; Tojo T; Akizuki M; Yamagata H
    Scand J Rheumatol Suppl; 1986; 61():26-7. PubMed ID: 3473640
    [No Abstract]   [Full Text] [Related]  

  • 47. [Progress on diagnosis of Sjogren's syndrome].
    Toarikai K; Tamura I; Sato M
    Nihon Naika Gakkai Zasshi; 1991 Nov; 80(11):1730-5. PubMed ID: 1783836
    [No Abstract]   [Full Text] [Related]  

  • 48. Sjögren's syndrome: a condition with features of chronic graft-versus-host disease: does duct cell adhesion or permeability play a role in pathogenesis?
    Lamey PJ; Lundy FT; Al-Hashimi I
    Med Hypotheses; 2004; 62(5):825-9. PubMed ID: 15082115
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Isotypes and subtypes of anti-SS-A and/or SS-B antibodies in different subgroups of Sjögren's syndrome].
    Takaya M; Ichikawa Y
    Nihon Rinsho; 1995 Oct; 53(10):2429-33. PubMed ID: 8531350
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Spontaneous splenic hypofunction in systemic lupus erythematosus and primary Sjögren syndrome].
    Vallés R; Rivero I; Morán D; Diumenjo MS
    Medicina (B Aires); 1993; 53(5):397-400. PubMed ID: 8201927
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Human combinatorial autoantibodies and mouse monoclonal antibodies to PDC-E2 produce abnormal apical staining of salivary glands in patients with coexistent primary biliary cirrhosis and Sjögren's syndrome.
    Tsuneyama K; Van de Water J; Nakanuma Y; Cha S; Ansari A; Coppel R; Gershwin ME
    Hepatology; 1994 Oct; 20(4 Pt 1):893-8. PubMed ID: 7927231
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Epitopic targets for autoantibodies in systemic lupus erythematosus and Sjögren's syndrome.
    Chan EK; Tan EM
    Curr Opin Rheumatol; 1989 Oct; 1(3):376-81. PubMed ID: 2484307
    [No Abstract]   [Full Text] [Related]  

  • 53. Sjögren's syndrome.
    Manthorpe R; Prause JU
    Ann Intern Med; 1985 Oct; 103(4):640-1. PubMed ID: 4037569
    [No Abstract]   [Full Text] [Related]  

  • 54. Primary biliary cirrhosis and Sjögren's syndrome: case report.
    Mandel L; Dehlinger N
    J Oral Maxillofac Surg; 2003 Nov; 61(11):1358-61. PubMed ID: 14613096
    [No Abstract]   [Full Text] [Related]  

  • 55. [Immunologic abnormalities and classification of Sjögren's syndrome--Mikulicz syndrome and its relationship to sicca syndrome].
    Yamauchi K
    Nihon Rinsho; 1983; 41(1):224-7. PubMed ID: 6842855
    [No Abstract]   [Full Text] [Related]  

  • 56. First international symposium on Sjögren's syndrome: suggested criteria for classification.
    Fox RI; Robinson C; Curd J; Michelson P; Bone R; Howell FV
    Scand J Rheumatol Suppl; 1986; 61():28-30. PubMed ID: 3473644
    [No Abstract]   [Full Text] [Related]  

  • 57. Degree of modification of Ro60 by the lipid peroxidation by-product 4-hydroxy-2-nonenal may differentially induce Sjögren syndrome or systemic lupus erythematosus in BALB/c mice.
    Kurien BT; Porter A; Dorri Y; Iqbal S; D'Souza A; Singh A; Asfa S; Cartellieri M; Mathias K; Matsumoto H; Bachmann M; Hensley K; Scofield RH
    Free Radic Biol Med; 2011 May; 50(10):1222-33. PubMed ID: 20946951
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical, serologic, and genetic profiles of patients with associated Sjögren's syndrome and systemic lupus erythematosus.
    Szanto A; Szodoray P; Kiss E; Kapitany A; Szegedi G; Zeher M
    Hum Immunol; 2006 Nov; 67(11):924-30. PubMed ID: 17145372
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Systemic lupus erythematosus and Sjögren's syndrome.
    Curr Opin Rheumatol; 1989 Oct; 1(3):397-407. PubMed ID: 2701694
    [No Abstract]   [Full Text] [Related]  

  • 60. Antinuclear antibodies in lupus erythematosus and Sjögren's syndrome: clinical and immunological investigations.
    Speransky AI; Ivanova MI; Rjazantceva TA; Piven VA; Bulanova TD
    Scand J Rheumatol Suppl; 1987; 67():39-43. PubMed ID: 3330862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.